Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing.

Shee K, Muller KE, Marotti J, Miller TW, Wells WA, Tsongalis GJ.

Am J Pathol. 2018 Oct 29. pii: S0002-9440(18)30558-3. doi: 10.1016/j.ajpath.2018.08.020. [Epub ahead of print] Review.

PMID:
30385093
2.

Review of methods for intraoperative margin detection for breast conserving surgery.

Maloney BW, McClatchy DM, Pogue BW, Paulsen KD, Wells WA, Barth RJ.

J Biomed Opt. 2018 Oct;23(10):1-19. doi: 10.1117/1.JBO.23.10.100901.

PMID:
30369108
3.

Light scattering measured with spatial frequency domain imaging can predict stromal versus epithelial proportions in surgically resected breast tissue.

McClatchy DM, Rizzo EJ, Wells WA, Black CC, Paulsen KD, Kanick SC, Pogue BW.

J Biomed Opt. 2018 Sep;24(7):1-11. doi: 10.1117/1.JBO.24.7.071605.

PMID:
30264552
4.

Micro-computed tomography enables rapid surgical margin assessment during breast conserving surgery (BCS): correlation of whole BCS micro-CT readings to final histopathology.

McClatchy DM 3rd, Zuurbier RA, Wells WA, Paulsen KD, Pogue BW.

Breast Cancer Res Treat. 2018 Sep 17. doi: 10.1007/s10549-018-4951-3. [Epub ahead of print]

PMID:
30225621
5.

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.

Zignol M, Cabibbe AM, Dean AS, Glaziou P, Alikhanova N, Ama C, Andres S, Barbova A, Borbe-Reyes A, Chin DP, Cirillo DM, Colvin C, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Hussain A, Ismail N, Kamal SMM, Khanzada FM, Kimerling M, Kohl TA, Mansjö M, Miotto P, Mukadi YD, Mvusi L, Niemann S, Omar SV, Rigouts L, Schito M, Sela I, Seyfaddinova M, Skenders G, Skrahina A, Tahseen S, Wells WA, Zhurilo A, Weyer K, Floyd K, Raviglione MC.

Lancet Infect Dis. 2018 Jun;18(6):675-683. doi: 10.1016/S1473-3099(18)30073-2. Epub 2018 Mar 21. Erratum in: Lancet Infect Dis. 2018 Mar 27;:.

6.

Calibration and analysis of a multimodal micro-CT and structured light imaging system for the evaluation of excised breast tissue.

McClatchy DM, Rizzo EJ, Meganck J, Kempner J, Vicory J, Wells WA, Paulsen KD, Pogue BW.

Phys Med Biol. 2017 Nov 10;62(23):8983-9000. doi: 10.1088/1361-6560/aa94b6.

7.

Onions and prevalence surveys: how to analyze and quantify tuberculosis case-finding gaps.

Wells WA.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1101-1113. doi: 10.5588/ijtld.17.0271.

PMID:
29037290
8.

A Patient-Specific 3D-Printed Form Accurately Transfers Supine MRI-Derived Tumor Localization Information to Guide Breast-Conserving Surgery.

Barth RJ Jr, Krishnaswamy V, Paulsen KD, Rooney TB, Wells WA, Rizzo E, Angeles CV, Marotti JD, Zuurbier RA, Black CC.

Ann Surg Oncol. 2017 Oct;24(10):2950-2956. doi: 10.1245/s10434-017-5979-z. Epub 2017 Aug 1.

9.

Triple-Negative Breast Cancer: Next-Generation Sequencing for Target Identification.

Marotti JD, de Abreu FB, Wells WA, Tsongalis GJ.

Am J Pathol. 2017 Oct;187(10):2133-2138. doi: 10.1016/j.ajpath.2017.05.018. Epub 2017 Jul 20. Review.

PMID:
28734944
10.

Reviewing the Evidence to Guide Clinical Care: Proliferative Breast Lesions in Breast Reduction Specimens.

Akintayo RM, Rosenkranz KM, Wells WA, Ridgway EB.

Ann Plast Surg. 2017 Oct;79(4):410-414. doi: 10.1097/SAP.0000000000001102. Review.

PMID:
28570457
11.

Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis.

Gomez GB, Dowdy DW, Bastos ML, Zwerling A, Sweeney S, Foster N, Trajman A, Islam MA, Kapiga S, Sinanovic E, Knight GM, White RG, Wells WA, Cobelens FG, Vassall A.

BMC Infect Dis. 2016 Dec 1;16(1):726.

12.

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice.

Uplekar M, Atre S, Wells WA, Weil D, Lopez R, Migliori GB, Raviglione M.

Eur Respir J. 2016 Dec;48(6):1571-1581. doi: 10.1183/13993003.00956-2016. Epub 2016 Oct 20. Review.

13.

Wide-field quantitative imaging of tissue microstructure using sub-diffuse spatial frequency domain imaging.

McClatchy DM 3rd, Rizzo EJ, Wells WA, Cheney PP, Hwang JC, Paulsen KD, Pogue BW, Kanick SC.

Optica. 2016 Jun 20;3(6):613-621. Epub 2016 Jun 9.

14.

Somatic gene mutation analysis of triple negative breast cancers.

Dillon JL, Mockus SM, Ananda G, Spotlow V, Wells WA, Tsongalis GJ, Marotti JD.

Breast. 2016 Oct;29:202-7. doi: 10.1016/j.breast.2016.06.018. Epub 2016 Jul 7.

PMID:
27397723
15.

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.

Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC.

Lancet Infect Dis. 2016 Oct;16(10):1185-1192. doi: 10.1016/S1473-3099(16)30190-6. Epub 2016 Jul 7.

16.

Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions.

Yan S, Coffing BN, Li Z, Xie H, Brennick JB, Beg HA, Froehlich HM, Wells WA.

Anticancer Res. 2016 Jun;36(6):2871-80.

PMID:
27272799
17.

Effective quality management practices in routine clinical next-generation sequencing.

de Abreu FB, Peterson JD, Amos CI, Wells WA, Tsongalis GJ.

Clin Chem Lab Med. 2016 May;54(5):761-71. doi: 10.1515/cclm-2015-1190.

18.

Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services.

Trajman A, Bastos ML, Belo M, Calaça J, Gaspar J, Dos Santos AM, Dos Santos CM, Brito RT, Wells WA, Cobelens FG, Vassall A, Gomez GB.

BMC Health Serv Res. 2016 Jan 22;16:27. doi: 10.1186/s12913-016-1269-x.

19.

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.

Knight GM, Gomez GB, Dodd PJ, Dowdy D, Zwerling A, Wells WA, Cobelens F, Vassall A, White RG.

PLoS One. 2015 Dec 30;10(12):e0145796. doi: 10.1371/journal.pone.0145796. eCollection 2015.

20.

Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas.

Chinyengetere F, Sekula DJ, Lu Y, Giustini AJ, Sanglikar A, Kawakami M, Ma T, Burkett SS, Eisenberg BL, Wells WA, Hoopes PJ, Demicco EG, Lazar AJ, Torres KE, Memoli V, Freemantle SJ, Dmitrovsky E.

BMC Cancer. 2015 Nov 10;15:886. doi: 10.1186/s12885-015-1883-8.

21.
22.

Achieving Systemic and Scalable Private Sector Engagement in Tuberculosis Care and Prevention in Asia.

Wells WA, Uplekar M, Pai M.

PLoS Med. 2015 Jun 23;12(6):e1001842. doi: 10.1371/journal.pmed.1001842. eCollection 2015 Jun. No abstract available.

23.

A Pilot Study of Ultrasound-Guided Cryoablation of Invasive Ductal Carcinomas up to 15 mm With MRI Follow-Up and Subsequent Surgical Resection.

Poplack SP, Levine GM, Henry L, Wells WA, Heinemann FS, Hanna CM, Deneen DR, Tosteson TD, Barth RJ Jr.

AJR Am J Roentgenol. 2015 May;204(5):1100-8. doi: 10.2214/AJR.13.12325.

24.

Molecular dyes used for surgical specimen margin orientation allow for intraoperative optical assessment during breast conserving surgery.

McClatchy DM 3rd, Krishnaswamy V, Kanick SC, Elliott JT, Wells WA, Barth RJ Jr, Paulsen KD, Pogue BW.

J Biomed Opt. 2015 Apr;20(4):040504. doi: 10.1117/1.JBO.20.4.040504.

25.

Breast MRI-detected cystic apocrine metaplasia: imaging features with microvessel analysis and histologic correlation.

diFlorio-Alexander RM, Marotti JD, Bond JS, Schwab MC, Memoli VA, Wells WA, Poplack SP.

AJR Am J Roentgenol. 2015 Jan;204(1):211-8. doi: 10.2214/AJR.14.12869.

PMID:
25539259
26.

Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma.

Muller KE, Tafe LJ, de Abreu FB, Peterson JD, Wells WA, Barth RJ, Marotti JD.

Hum Pathol. 2015 Feb;46(2):327-33. doi: 10.1016/j.humpath.2014.10.014. Epub 2014 Nov 4.

PMID:
25476122
27.

Stromal expression of miR-21 identifies high-risk group in triple-negative breast cancer.

MacKenzie TA, Schwartz GN, Calderone HM, Graveel CR, Winn ME, Hostetter G, Wells WA, Sempere LF.

Am J Pathol. 2014 Dec;184(12):3217-25. doi: 10.1016/j.ajpath.2014.08.020. Epub 2014 Nov 6.

28.

Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach.

Samkoe KS, Tichauer KM, Gunn JR, Wells WA, Hasan T, Pogue BW.

Cancer Res. 2014 Dec 15;74(24):7465-74. doi: 10.1158/0008-5472.CAN-14-0141. Epub 2014 Oct 24.

29.

Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment.

Jiang S, Pogue BW, Kaufman PA, Gui J, Jermyn M, Frazee TE, Poplack SP, DiFlorio-Alexander R, Wells WA, Paulsen KD.

Clin Cancer Res. 2014 Dec 1;20(23):6006-15. doi: 10.1158/1078-0432.CCR-14-1415. Epub 2014 Oct 7.

30.

Real-time electrical impedance variations in women with and without breast cancer.

Halter RJ, Hartov A, Poplack SP, diFlorio-Alexander R, Wells WA, Rosenkranz KM, Barth RJ, Kaufman PA, Paulsen KD.

IEEE Trans Med Imaging. 2015 Jan;34(1):38-48. doi: 10.1109/TMI.2014.2342719. Epub 2014 Jul 24.

31.

Structured light scatteroscopy.

Krishnaswamy V, Elliott JT, McClatchy DM 3rd, Barth RJ Jr, Wells WA, Pogue BW, Paulsen KD.

J Biomed Opt. 2014;19(7):070504. doi: 10.1117/1.JBO.19.7.070504.

PMID:
25057960
32.

Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimens.

Gospodarevskaya E, Tulloch O, Bunga C, Ferdous S, Jonas A, Islam S, Rahman M, Hussain MA, Haque MN, Egwaga S, Gardiner E, PrayGod G, Islam MA, Mann GH, Wells WA, Squire SB.

Int J Tuberc Lung Dis. 2014 Jul;18(7):810-7. doi: 10.5588/ijtld.13.0391.

PMID:
24902557
33.

Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.

Liu X, Mody K, de Abreu FB, Pipas JM, Peterson JD, Gallagher TL, Suriawinata AA, Ripple GH, Hourdequin KC, Smith KD, Barth RJ Jr, Colacchio TA, Tsapakos MJ, Zaki BI, Gardner TB, Gordon SR, Amos CI, Wells WA, Tsongalis GJ.

Clin Chem. 2014 Jul;60(7):1004-11. doi: 10.1373/clinchem.2014.225565. Epub 2014 May 12.

34.

Personalized therapy for breast cancer.

De Abreu FB, Schwartz GN, Wells WA, Tsongalis GJ.

Clin Genet. 2014 Jul;86(1):62-7. doi: 10.1111/cge.12381. Epub 2014 Apr 9. Review.

PMID:
24635704
35.

Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations.

Tsongalis GJ, Peterson JD, de Abreu FB, Tunkey CD, Gallagher TL, Strausbaugh LD, Wells WA, Amos CI.

Clin Chem Lab Med. 2014 May;52(5):707-14. doi: 10.1515/cclm-2013-0883.

PMID:
24334431
36.

The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine.

De Abreu FB, Wells WA, Tsongalis GJ.

Am J Pathol. 2013 Oct;183(4):1075-1083. doi: 10.1016/j.ajpath.2013.07.002. Epub 2013 Aug 3. Review.

37.

Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging.

Laughney AM, Krishnaswamy V, Rizzo EJ, Schwab MC, Barth RJ Jr, Cuccia DJ, Tromberg BJ, Paulsen KD, Pogue BW, Wells WA.

Breast Cancer Res. 2013;15(4):R61.

38.

Direct identification of breast cancer pathologies using blind separation of label-free localized reflectance measurements.

Eguizabal A, Laughney AM, García-Allende PB, Krishnaswamy V, Wells WA, Paulsen KD, Pogue BW, Lopez-Higuera JM, Conde OM.

Biomed Opt Express. 2013 Jun 12;4(7):1104-18. doi: 10.1364/BOE.4.001104. Print 2013 Jul 1.

39.

A comprehensive assay for CFTR mutational analysis using next-generation sequencing.

Abou Tayoun AN, Tunkey CD, Pugh TJ, Ross T, Shah M, Lee CC, Harkins TT, Wells WA, Tafe LJ, Amos CI, Tsongalis GJ.

Clin Chem. 2013 Oct;59(10):1481-8. doi: 10.1373/clinchem.2013.206466. Epub 2013 Jun 17.

40.

Microwave imaging for neoadjuvant chemotherapy monitoring: initial clinical experience.

Meaney PM, Kaufman PA, Muffly LS, Click M, Poplack SP, Wells WA, Schwartz GN, di Florio-Alexander RM, Tosteson TD, Li Z, Geimer SD, Fanning MW, Zhou T, Epstein NR, Paulsen KD.

Breast Cancer Res. 2013 Apr 24;15(2):R35. doi: 10.1186/bcr3418.

41.

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.

Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M.

Lancet Infect Dis. 2013 May;13(5):449-58. doi: 10.1016/S1473-3099(13)70025-2. Epub 2013 Mar 24. Review.

42.

System analysis of spatial frequency domain imaging for quantitative mapping of surgically resected breast tissues.

Laughney AM, Krishnaswamy V, Rice TB, Cuccia DJ, Barth RJ, Tromberg BJ, Paulsen KD, Pogue BW, Wells WA.

J Biomed Opt. 2013 Mar;18(3):036012. doi: 10.1117/1.JBO.18.3.036012.

43.

A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue.

McGowan MM, Eisenberg BL, Lewis LD, Froehlich HM, Wells WA, Eastman A, Kuemmerle NB, Rosenkrantz KM, Barth RJ Jr, Schwartz GN, Li Z, Tosteson TD, Beaulieu BB Jr, Kinlaw WB.

Breast Cancer Res Treat. 2013 Feb;138(1):175-83. doi: 10.1007/s10549-013-2446-9. Epub 2013 Feb 16.

44.

Scanning in situ spectroscopy platform for imaging surgical breast tissue specimens.

Krishnaswamy V, Laughney AM, Wells WA, Paulsen KD, Pogue BW.

Opt Express. 2013 Jan 28;21(2):2185-94. doi: 10.1364/OE.21.002185.

45.

ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells.

Balboni AL, Hutchinson JA, DeCastro AJ, Cherukuri P, Liby K, Sporn MB, Schwartz GN, Wells WA, Sempere LF, Yu PB, DiRenzo J.

Cancer Res. 2013 Jan 15;73(2):1020-30. doi: 10.1158/0008-5472.CAN-12-2862. Epub 2012 Dec 14.

46.

The multi-step process of building TB/HIV collaboration in Cambodia.

Eang MT, Vun MC, Eam KK, Sovannarith S, Sopheap S, Bora N, Yadav R, Fujita M, Tomas B, Ghidinelli M, van Maaren P, Wells WA.

Health Res Policy Syst. 2012 Oct 18;10:34. doi: 10.1186/1478-4505-10-34. Review.

47.

Scatter spectroscopic imaging distinguishes between breast pathologies in tissues relevant to surgical margin assessment.

Laughney AM, Krishnaswamy V, Rizzo EJ, Schwab MC, Barth RJ, Pogue BW, Paulsen KD, Wells WA.

Clin Cancer Res. 2012 Nov 15;18(22):6315-25. doi: 10.1158/1078-0432.CCR-12-0136. Epub 2012 Aug 20.

48.

ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.

Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Wells WA, Winter JN, Horning SJ, Dar AR, Shustik C, Stewart DA, Crump M, Djurfeldt MS, Chen BE, Shepherd LE; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group.

N Engl J Med. 2012 Feb 2;366(5):399-408. doi: 10.1056/NEJMoa1111961. Epub 2011 Dec 11.

49.

Implications of the current tuberculosis treatment landscape for future regimen change.

Wells WA, Konduri N, Chen C, Lee D, Ignatius HR, Gardiner E, Schwalbe NR.

Int J Tuberc Lung Dis. 2011 Jun;15(6):746-53. doi: 10.5588/ijtld.10.0094.

PMID:
21575293
50.

Size and usage patterns of private TB drug markets in the high burden countries.

Wells WA, Ge CF, Patel N, Oh T, Gardiner E, Kimerling ME.

PLoS One. 2011 May 4;6(5):e18964. doi: 10.1371/journal.pone.0018964.

Supplemental Content

Loading ...
Support Center